General American Investors’s Pfizer PFE Stock Holding History

General American Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.77M	Sell	405,808 -100,000	-20%	-$2.62M	0.58%	47
2026 Q1	$14.2M	Hold	505,808	–	–	0.93%	39
2025 Q4	$12.6M	Hold	505,808	–	–	0.71%	44
2025 Q3	$12.9M	Sell	505,808 -10,000	-2%	-$247K	0.75%	46
2025 Q2	$12.5M	Hold	515,808	–	–	0.8%	41
2025 Q1	$13.1M	Hold	515,808	–	–	0.95%	37
2024 Q4	$13.7M	Sell	515,808 -25,000	-5%	-$678K	0.95%	36
2024 Q3	$15.7M	Buy	540,808 +115,000	+27%	+$3.35M	1.08%	33
2024 Q2	$11.9M	Buy	425,808 +60,000	+16%	+$1.65M	0.83%	41
2024 Q1	$10.2M	Hold	365,808	–	–	0.73%	44
2023 Q4	$10.5M	Hold	365,808	–	–	0.83%	39
2023 Q3	$12.1M	Hold	365,808	–	–	1.09%	30
2023 Q2	$13.4M	Hold	365,808	–	–	1.17%	27
2023 Q1	$14.9M	Buy	365,808 +20,000	+6%	+$864K	1.41%	22
2022 Q4	$17.7M	Hold	345,808	–	–	1.73%	18
2022 Q3	$15.1M	Hold	345,808	–	–	1.57%	24
2022 Q2	$18.1M	Hold	345,808	–	–	1.82%	19
2022 Q1	$17.9M	Hold	345,808	–	–	1.46%	23
2021 Q4	$20.4M	Hold	345,808	–	–	1.6%	18
2021 Q3	$14.9M	Sell	345,808 -20,000	-5%	-$886K	1.26%	27
2021 Q2	$14.3M	Sell	365,808 -25,000	-6%	-$972K	1.2%	29
2021 Q1	$14.2M	Hold	390,808	–	–	1.32%	27
2020 Q4	$14.4M	Buy	390,808 +5,246	+1%	+$192K	1.42%	25
2020 Q3	$13.4M	Hold	385,562	–	–	1.55%	21
2020 Q2	$12M	Hold	385,562	–	–	1.52%	22
2020 Q1	$11.9M	Hold	385,562	–	–	1.62%	20
2019 Q4	$14.3M	Buy	385,562 +36,890	+11%	+$1.31M	1.31%	30
2019 Q3	$11.9M	Hold	348,672	–	–	1.17%	33
2019 Q2	$14.3M	Hold	348,672	–	–	1.36%	31
2019 Q1	$14M	Hold	348,672	–	–	1.39%	30
2018 Q4	$14.4M	Sell	348,672 -52,700	-13%	-$2.19M	1.52%	27
2018 Q3	$16.8M	Hold	401,372	–	–	1.44%	26
2018 Q2	$13.8M	Hold	401,372	–	–	1.26%	31
2018 Q1	$13.5M	Hold	401,372	–	–	1.28%	31
2017 Q4	$13.8M	Hold	401,372	–	–	1.34%	30
2017 Q3	$13.6M	Sell	401,372 -84,320	-17%	-$2.71M	1.29%	36
2017 Q2	$15.5M	Hold	485,692	–	–	1.57%	31
2017 Q1	$15.8M	Hold	485,692	–	–	1.54%	31
2016 Q4	$15M	Hold	485,692	–	–	1.51%	32
2016 Q3	$15.6M	Hold	485,692	–	–	1.59%	27
2016 Q2	$16.2M	Sell	485,692 -152,830	-24%	-$4.88M	1.69%	26
2016 Q1	$18M	Hold	638,522	–	–	1.86%	23
2015 Q4	$19.6M	Hold	638,522	–	–	1.79%	23
2015 Q3	$19M	Hold	638,522	–	–	1.72%	25
2015 Q2	$20.3M	Sell	638,522 -105,400	-14%	-$3.44M	1.67%	28
2015 Q1	$24.6M	Sell	743,922 -52,700	-7%	-$1.68M	2.02%	20
2014 Q4	$23.5M	Hold	796,622	–	–	1.88%	22
2014 Q3	$22.3M	Hold	796,622	–	–	1.78%	27
2014 Q2	$22.4M	Hold	796,622	–	–	1.82%	25
2014 Q1	$24.3M	Hold	796,622	–	–	2.03%	19
2013 Q4	$23.1M	Hold	796,622	–	–	1.88%	21
2013 Q3	$21.7M	Hold	796,622	–	–	1.89%	22
2013 Q2	$21.2M	Buy	+796,622	New	+$22M	1.93%	21

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

General American Investors's PFE Position: Q2 2026 in Review

General American Investors reduced its Pfizer (PFE) stake by 20% in Q2 2026, selling an estimated $2.62M and leaving 405,808 shares worth $9.77M. The position accounts for 0.58% of the portfolio, ranked #47.

General American Investors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.6M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

General American Investors held 405,808 shares of Pfizer worth $9.77M as of Q2 2026.
General American Investors sold 100,000 Pfizer shares in Q2 2026, an estimated $2.62M.
Pfizer made up 0.58% of General American Investors's portfolio in Q2 2026, its #47 holding.
General American Investors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
General American Investors's Pfizer position peaked at $24.6M in Q1 2015.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on General American Investors's 13F filing for Q2 2026, filed 31 Jul 2026.